Skip to content

Hypothermia and Circulatory Arrest During Surgery on the Ascending Aorta: A Comparison Between Two Cooling Methods

Hypothermia and Circulatory Arrest During Surgery on the Ascending Aorta: A Comparison Between Two Cooling Methods

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01306734
Enrollment
20
Registered
2011-03-02
Start date
2011-03-31
Completion date
2012-12-31
Last updated
2012-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ascending Aorta Aneurism

Keywords

Extracorporeal circulation, Deep Hypothermic Circulatory Arrest, aortic aneurism, neurological injury, inflammation, coagulation

Brief summary

PURPOSE: To compare crash cooling versus gradient cooling methods for patients undergoing planned surgery on the ascending aorta in deep hypothermic circulatory arrest. To investigate the impact of hypothermia and circulatory arrest on the coagulation, stress-response, and cerebral outcome. BACKGROUND: Cooling to 18 °C using extracorporeal circulation allows for circulatory arrest during surgery on the ascending aorta. Two different methods are used either lowering the temperature of the blood by 10 °C at a time, gradient cooling, or as cold as possible, crash cooling. The distribution of hypothermia is expected to be different for the two methods, the latter predominantly cooling the body core. The influence on the physiological response is expected to vary with the two methods. The surgical procedure and the cooling greatly elicit a stress response and the coagulation is profoundly influenced. There can be adverse effects on the neurological outcome due to the procedure. The two methods are considered equal, but have never been subjected to comparison. The surgery and circulatory changes can have a negative influence on the cerebral outcome . METHODS: Twenty patients between 18 and 80 yrs randomized either to crash cooling or gradient cooling, ten patients in each group.. Patients with severe comorbidities or known coagulopathy are excluded. Anesthesia and operation as performed routinely in the department. The primary endpoint is duration of cooling, secondary endpoints include coagulation parameters (thromboelastography, clot stability), stress response parameters (adhesion molecule expression on endothelial cells, oxidative stress analysis, inflammatory markers), neuropsychological tests, MRI of the cerebrum, markers of cerebral ischemia, and ultrasound imaging of the great vessels for detection of air bubbles. Baseline values are obtained for all parameters.

Interventions

None listed

Sponsors

Aarhus University Hospital
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for surgery on the ascending aorta * Need for deep hypothermic circulatory arrest during the procedure

Exclusion criteria

* Known coagulopathy * Ejection fraction less than 30 % * Severe psychiatric or neurological disease * Severe liver disease * Severely reduced lung function * Glomerular filtration rate less than 15 ml/min/1.73 m2

Design outcomes

Primary

MeasureTime frame
Duration of coolingintraoperatively

Secondary

MeasureTime frameDescription
Markers of neurological injurybaseline, postoperatives-100b, Neuron specific enolase
neurological exambaseline, postoperative, after 4 months
cognitive testbaseline, postoperative, after 4 months
MRI of cerebrumBaseline prior to surgery and 4 to 5 days postoperativelyStandard perfusion-weighed Magnetic Resonance imaging of the cerebrum. The same investigator describes all images. No use of contrast agents.
Markers of oxidative stressperioperatively
Coagulation parametersperioperatively
markers of elevated inflammatory responseperioperatively

Countries

Denmark

Contacts

Primary ContactHans Kirkegaard, MD, Ph.D.
hans.kirkegaard@dadlnet.dk+4589498852
Backup ContactKristian K Andersen, MD
kristian.kjaer.andersen@ki.au.dk+4521680494

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026